Skip to evidence report

IPSC.mesodermal_primed: Studies — page 12

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,329 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 11,001–12,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for IPSC.mesodermal_primed
#Trait / studyIndividual trait IDMean IC score
11001DCTN1/ERBIN ratioGCST903144293.21e-04
11002GNLY/GZMA ratioGCST903149493.18e-04
11003Mandibular retrognathiaFING000007843.18e-04
11004lymphocyte (absolute count, mean, inv-norm transformed)GCST904754263.18e-04
11005LIFR levelsGCST904697693.17e-04
11006CTSD levelsGCST904689103.16e-04
11007AmygNuclei lh volume Accessory-Basal-nucleusGCST900026503.15e-04
11008FGF21/LEP ratioGCST903148103.14e-04
11009ENPP2/TNFRSF11B ratioGCST903146723.13e-04
11010EGF/PPIB ratioGCST903146123.12e-04
11011ANGPT1/APP ratioGCST903132603.12e-04
11012Gallstone diseaseGCST901285183.11e-04
11013MGLL/PTPN6 ratioGCST903154403.10e-04
11014PFKFB2 levelsGCST904702153.09e-04
11015IRAG2/TBC1D23 ratioGCST903151913.05e-04
11016Type 1 diabetesGCST900140233.04e-04
11017NUBP1 levelsGCST904701003.04e-04
11018DTI TBSS MD Anterior corona radiata RGCST903845943.01e-04
11019Glaucoma (primary open-angle)GCST903997253.01e-04
11020Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903027233.01e-04
11021Cough on most days | Medical informationUKBB000001532.99e-04
11022F2R levelsGCST900120102.99e-04
11023SUSD2 levelsGCST904707872.98e-04
11024ESAM/SORT1 ratioGCST903147162.98e-04
11025Job involved shift work | Employment historyUKBB000003822.98e-04
11026CRTAM/VCAM1 ratioGCST903142812.97e-04
11027CCL2 levelsGCST900120072.96e-04
11028CLMP/GFRA1 ratioGCST903141332.94e-04
11029Bone marrow fat fraction of left proximal femurGCST906523922.94e-04
11030GADD45GIP1 levelsGCST904692932.94e-04
11031QDPR/THOP1 ratioGCST903157572.93e-04
11032Graves' diseaseGCST900186272.92e-04
11033DAPP1/SDC4 ratioGCST903143992.92e-04
11034Omega-3 fatty acids to total fatty acids percentageGCST905024662.91e-04
11035DCTN6 levelsGCST904689602.91e-04
11036GZMA/GZMH ratioGCST903150082.90e-04
11037CPXM1/MDK ratioGCST903142212.90e-04
11038Squamous cell carcinoma (PheCode 172.22)GCST904755832.90e-04
11039MEGF9/MET ratioGCST903154182.89e-04
11040CLPS/PRSS2 ratioGCST903141412.88e-04
11041Repeated disturbing thoughts of stressful experience in past month | Traumatic eventsUKBB000007502.87e-04
11042DTI TBSS FA Corticospinal tract RGCST903843862.87e-04
11043Haematocrit percentage (UKB data field 30030)GCST904680732.87e-04
11044ANGPT1/DKK1 ratioGCST903132632.87e-04
11045CRYGD levelsGCST904688762.87e-04
11046CASP10 levelsGCST904685422.87e-04
11047Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448ECGU0004482.86e-04
11048NCK2/VASH1 ratioGCST903155262.85e-04
11049CST3/TIMP1 ratioGCST903143002.84e-04
11050CST3/RETN ratioGCST903142972.80e-04
11051mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST904754662.80e-04
11052C7 levelsGCST904685022.79e-04
11053Plasma homoarginine levels in chronic kidney diseaseGCST902653452.78e-04
11054CPXM1/LGMN ratioGCST903142202.77e-04
11055CD70 levelsGCST904686452.77e-04
11056OPHN1 levelsGCST904701262.77e-04
11057eosinophil (absolute count, mean, inv-norm transformed)GCST904752912.74e-04
11058DNAJA2/PRDX5 ratioGCST903145062.74e-04
11059CANT1/HSPB1 ratioGCST903136172.74e-04
11060GlaucomaGCST904753832.73e-04
11061DNMBP/TJAP1 ratioGCST903145212.72e-04
11062IQGAP2/STX4 ratioGCST903151902.71e-04
11063Lysophosphatidylcholine (22:6) [sn2] levelsGCST900241852.71e-04
11064Acylcarnitine (18:2) levelsGCST900246232.70e-04
11065SDC4/SERPINE1 ratioGCST903158192.69e-04
11066DTI TBSS L3 Genu of corpus callosumGCST903845262.67e-04
11067C36:4 Phosphatidylethanolamine levels in chronic kidney diseaseGCST902573572.67e-04
11068ATP5IF1/FIS1 ratioGCST903133852.66e-04
11069VSTM2B levelsGCST904710562.65e-04
11070BCR/FOXO1 ratioGCST903134902.64e-04
11071Cholesterol levels in very large HDLGCST905003222.64e-04
11072Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST904762892.64e-04
11073Hypoplasia of dental enamel, including avohilmoFING000006522.63e-04
11074F2R/GP6 ratioGCST903147302.61e-04
11075Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levelsGCST903179642.61e-04
11076Other arthritis (FG)FING000009642.61e-04
11077FCRL5 levelsGCST904692082.60e-04
11078Benign neoplasm of other and unspecified endocrine glandsFING000001592.60e-04
11079AKT1S1/FHIT ratioGCST903132282.59e-04
11080IDP dMRI TBSS MD Corticospinal tract RGCST900040332.59e-04
11081BronchitisFING000002282.58e-04
11082CD83/IL12A_IL12B ratioGCST903139052.58e-04
11083DSC2/EFEMP1 ratioGCST903145552.58e-04
11084CLEC1B/DAB2 ratioGCST903140862.58e-04
11085aseg rh number HolesBeforeFixingGCST900026472.57e-04
11086CST3/TAFA5 ratioGCST903142982.56e-04
11087T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST903206602.55e-04
11088Cholesterol levels in small HDLGCST900929442.55e-04
11089KLRD1/LY9 ratioGCST903152612.55e-04
11090Acute pancreatitisGCST902553752.54e-04
11091CRNN levelsGCST904688692.54e-04
11092All dysplastic lesions of the cervix uteri, vagina or vulvaFING000000612.54e-04
11093Sum eosinophil basophil countsGCST0046242.52e-04
11094CDH1/CDH17 ratioGCST903139452.50e-04
11095GP1BA/SELP ratioGCST903149582.50e-04
11096USP25 levelsGCST904710192.50e-04
11097Omega-3 fatty acid levelsGCST905024402.50e-04
11098Sphingomyelin (d18:1/20:0, d16:1/22:0) levelsGCST902000012.50e-04
11099CCL20 levelsGCST904685722.49e-04
11100RGS10 levelsGCST904704652.49e-04
11101FASLG levelsGCST904691912.49e-04
11102CHCHD6 levelsGCST904687392.48e-04
11103PLA2G15 levelsGCST904702452.48e-04
11104Chronic diseases of tonsils and adenoidsFING000002832.47e-04
11105KLK6/PTPRN2 ratioGCST903152562.47e-04
11106Acute appendicitis, with complicationsFING000000192.47e-04
11107DLG4 levelsGCST904690012.46e-04
11108CCL24 levelsGCST904685762.45e-04
11109BTN3A2 levelsGCST904684812.44e-04
11110Noninflammatory disorders of female genital tractFING000008822.44e-04
11111GOPC levelsGCST904693772.43e-04
11112AP3B1 levelsGCST904683252.43e-04
11113PCDH1 levelsGCST904701702.43e-04
11114Concentration of medium HDL particlesGCST904986222.43e-04
111151-margaroyl-2-linoleoyl-GPC (17:0/18:2) metabolite levelGCST906160132.42e-04
11116Other hypothyroidism | Disorders of thyroid glandUKBB000006112.42e-04
11117F2R/SPINT2 ratioGCST903147372.42e-04
11118Right ventricular stroke volume (MTAG)GCST901345942.41e-04
11119Asthma | Chronic lower respiratory diseasesUKBB000000532.41e-04
11120TSC22D1 levelsGCST904709732.41e-04
11121Asthma | respiratoryUKBB000000542.40e-04
11122CD209/GP2 ratioGCST903137512.40e-04
11123CC2D1A/WWP2 ratioGCST903136682.40e-04
11124STX8 levelsGCST904707762.40e-04
11125CANT1/GSTA1 ratioGCST903136162.39e-04
11126Ulcerative colitis (PheCode 555.2)GCST900441552.38e-04
11127Primary biliary cholangitisGCST900614402.37e-04
11128MYCT1 levelsGCST906180462.37e-04
11129ITGAM levelsGCST904696382.37e-04
11130RRM2 levelsGCST904705012.37e-04
11131ACADSB levelsGCST904681952.36e-04
11132CALCOCO1/TBC1D5 ratioGCST903136102.35e-04
11133CFI levelsGCST904687302.35e-04
11134SarcoidosisGCST905034832.34e-04
11135PDGFA/SNAP23 ratioGCST903156192.33e-04
11136Hypothyroidism NOS | endocrine/metabolicUKBB000003362.32e-04
11137GRAP2/SNX9 ratioGCST903149882.32e-04
11138SERPINB6/TXNDC5 ratioGCST903158322.32e-04
11139Dermatitis and eczemaFING000004022.31e-04
11140GZMA/TNFRSF8 ratioGCST903150142.31e-04
11141AsthmaGCST900185752.30e-04
11142Chromatiales abundance in stoolGCST900323182.30e-04
11143Urinary calculus (PheCode 594)GCST904761432.29e-04
11144IL3RA levelsGCST904695962.29e-04
11145Paraproteinemia (PheCode 270.32)GCST904757102.28e-04
11146MESD/SNX9 ratioGCST903154232.28e-04
11147Operative procedures - Injection of therapeutic substance into joint | Summary OperationsUKBB000005822.28e-04
11148Calcium levels (UKB data field 30680)GCST904680652.27e-04
11149CLSTN3 levelsGCST904687902.26e-04
11150IGF1 levelsGCST904680782.24e-04
11151Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020692.23e-04
11152CD2AP levelsGCST904686172.23e-04
11153BID levelsGCST904684442.23e-04
11154APOA1 levelsGCST904971222.21e-04
11155GOPC/IRAK4 ratioGCST903149542.21e-04
11156CEACAM6 levelsGCST904686972.20e-04
11157IL32 levelsGCST904695912.20e-04
11158CHI3L1/HSPG2 ratioGCST903140432.20e-04
11159RABEP1 levelsGCST904704142.19e-04
11160KITLG/PLTP ratioGCST903152522.19e-04
11161PDLIM7/TBC1D23 ratioGCST903156402.18e-04
11162PILRA/TNFRSF1A ratioGCST903156552.17e-04
11163CD164 levelsGCST904686022.17e-04
11164CST3/IL18BP ratioGCST903142942.16e-04
11165Lymphocyte countGCST900187422.15e-04
11166Femoral herniaFING000005402.15e-04
11167Eosinophill count (UKB data field 30150)GCST904680682.15e-04
11168CD59/PI3 ratioGCST903138582.14e-04
11169STK4 levelsGCST904707672.14e-04
11170CKAP4/PGF ratioGCST903140752.12e-04
11171PTPN1/WWP2 ratioGCST903157462.11e-04
11172FUT8/VEGFC ratioGCST903148962.11e-04
11173Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB000001012.10e-04
11174CD48/SLAMF7 ratioGCST903138422.10e-04
11175Rheumatoid arthritisGCST901322242.10e-04
11176SDC4 levelsGCST904705592.10e-04
11177MITD1/SNX9 ratioGCST903154542.10e-04
11178C19ORF12 levelsGCST904684832.09e-04
11179Liver likingGCST900947942.08e-04
11180HPSE levelsGCST904694732.08e-04
11181Later onset COPDFING000007142.07e-04
11182CD40/ITGB5 ratioGCST903138162.07e-04
11183EDAR/TMSB10 ratioGCST903145902.06e-04
11184Other/unspecified rheumatoid arthritisFING000011262.06e-04
11185F2R/ITGB1BP2 ratioGCST903147312.04e-04
11186PRKAR2A levelsGCST904703272.03e-04
11187MITD1/WWP2 ratioGCST903154582.03e-04
11188DNAJC9 levelsGCST904690182.02e-04
11189IFNLR1 levelsGCST904695182.02e-04
11190Other Crohn's diseaseFING000009922.01e-04
11191GFRA1/TNFRSF1A ratioGCST903149242.01e-04
11192CTSZ/SMPDL3A ratioGCST903143222.01e-04
11193Psoriatic arthritisGCST902439562.00e-04
11194Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary OperationsUKBB000005711.99e-04
11195CD160/CXCL16 ratioGCST903137281.99e-04
11196Principal component-derived dietary pattern 21GCST901330261.99e-04
11197HTRA2/TRIAP1 ratioGCST903150991.98e-04
11198JAM3 levelsGCST904696601.98e-04
11199CASP1 levelsGCST904685431.96e-04
11200Carnitine levelsGCST902434811.96e-04
11201lymphocyte (fraction, mean, inv-norm transformed)GCST904754351.96e-04
11202PCDH9 levelsGCST904701721.96e-04
11203EDAR/SDC4 ratioGCST903145851.96e-04
11204Free cholesterol to total lipids ratio in large VLDLGCST900928731.95e-04
11205rfMRI connectivity (ICA100 edge 605)GCST900054581.94e-04
11206PODXL levelsGCST904702801.93e-04
11207TNFRSF14 levelsGCST904709071.93e-04
11208VEGFC/ZBTB16 ratioGCST903159461.92e-04
11209Frequency of heavy DIY in last 4 weeks | Physical activityUKBB000002631.92e-04
11210X-12707 levelsGCST902005021.91e-04
11211CLC levelsGCST904687621.91e-04
11212mean corpuscular volume (MCV, mean, inv-norm transformed)GCST904754701.88e-04
11213CCL22/PDGFB ratioGCST903136921.87e-04
11214T1 FreeSurfer a2009s rh S temporal sup volumeGCST903851101.86e-04
11215Lysophosphatidylcholine (26:0) [sn1] levelsGCST900254271.86e-04
11216APOH levelsGCST904683401.85e-04
11217CEACAM20 levelsGCST904686931.85e-04
11218CHGB levelsGCST904687421.85e-04
11219Right bundle branch block (PheCode 426.31)GCST904759571.85e-04
11220FHIT/MAX ratioGCST903148181.85e-04
11221DKK4 levelsGCST904689991.84e-04
11222ACVRL1/TNFRSF9 ratioGCST903131601.83e-04
11223pro-brain natriuretic peptide (proBNP, mean, inv-norm transformed)GCST904763121.83e-04
11224BCL2L15 levelsGCST904684311.83e-04
11225Respiratory disease (confirmatory factor analysis Factor 11)GCST903093451.82e-04
11226Plasma methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655081.82e-04
11227ITGB5/SIAE ratioGCST903152341.82e-04
11228Ulcerative ileocolitisFING000013921.82e-04
11229MIA levelsGCST904699031.81e-04
11230EGLN1 levelsGCST904690871.80e-04
11231Mean reticulocyte volume | Blood countUKBB000004511.79e-04
11232CD58/IFNGR1 ratioGCST903138491.78e-04
11233CALCOCO1/CRACR2A ratioGCST903135981.78e-04
11234PEAR1/SPINT2 ratioGCST903156441.77e-04
11235IDP dMRI TBSS L1 Corticospinal tract RGCST900040811.77e-04
11236Urine adenosine levels in chronic kidney diseaseGCST902647571.75e-04
11237TCN1 levelsGCST904708191.75e-04
11238GSN levelsGCST904694091.74e-04
11239SCPEP1 levelsGCST904705531.74e-04
11240Concentration of large HDL particlesGCST904978361.74e-04
11241APP/FKBP1B ratioGCST903133231.72e-04
11242CCL23 levelsGCST904685751.72e-04
11243Total lipids in medium HDLGCST904986041.71e-04
11244MMP9/PLTP ratioGCST903154711.71e-04
11245ConjunctivitisFING000003461.71e-04
11246ADM levelsGCST900119961.71e-04
11247AsthmaGCST904752591.70e-04
11248A4GALT levelsGCST904274571.70e-04
11249Pregnenolone sulfate levelsGCST901998731.70e-04
11250TCL1A/TNFRSF13C ratioGCST903159121.70e-04
11251Systemic connective tissue disordersFING000013501.69e-04
11252TNFRSF1B levelsGCST904709111.69e-04
11253CD79B/TNFRSF4 ratioGCST903139031.69e-04
11254ARHGEF12 levelsGCST904683581.68e-04
11255Anorexia (incl.atypical)FING000000931.68e-04
11256EPHB4/ESAM ratioGCST903146791.67e-04
11257CD48/CRTAM ratioGCST903138391.67e-04
11258Asthma (childhood onset)GCST0078001.66e-04
11259CA13/QDPR ratioGCST903135641.66e-04
11260Coffee max likingGCST900947391.66e-04
11261IDP T1 FIRST right pallidum volumeGCST900024431.65e-04
11262VPS4B levelsGCST904710471.64e-04
11263FCRL5/LY96 ratioGCST903148031.63e-04
11264FCRL2/SEMA7A ratioGCST903148001.63e-04
11265Prescriptions - prostaglandin analogUKBB000006971.63e-04
11266CD55/ITGB1 ratioGCST903138461.62e-04
11267SCARF1/TNFRSF14 ratioGCST903158121.61e-04
11268ECHS1 levelsGCST904690631.59e-04
11269neutrophil (fraction, minimum, inv-norm transformed)GCST904755411.59e-04
11270PDGFA/PLA2G4A ratioGCST903156151.59e-04
11271ITGB5/VSIR ratioGCST903152351.59e-04
11272Omega-6 fatty acid levelsGCST905025191.58e-04
11273mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST904754741.58e-04
11274VEGFD levelsGCST904710371.58e-04
11275Atopic dermatitisGCST900271611.57e-04
11276KIFBP/TBC1D23 ratioGCST903152501.57e-04
11277CD69/F2R ratioGCST903138771.57e-04
11278BAG3 levelsGCST904684161.57e-04
11279F2R/TNFRSF14 ratioGCST903147391.56e-04
11280IST1 levelsGCST904696321.56e-04
11281lymphocyte (fraction, maximum, inv-norm transformed)GCST904754321.55e-04
11282APRT/MIF ratioGCST903133361.55e-04
11283eosinophil (absolute count, maximum, inv-norm transformed)GCST904752881.55e-04
11284Breast cancer (triple negative or BRCA1-positive)GCST0101001.55e-04
11285ICAM3/SLAMF7 ratioGCST903151231.55e-04
11286Triacylglycerol_47:4_[M+NH4]1+ levelsGCST900603911.54e-04
11287SPOCK1 levelsGCST904707301.54e-04
11288Prostate cancerGCST900118081.53e-04
11289CD160/NCR1 ratioGCST903137321.53e-04
11290Adenocarcinoma and papilloma adenocarcinoma of rectumFING000000391.53e-04
11291Free cholesterol in small HDL (UKB data field 23577)GCST902696741.53e-04
11292ICD10 N87: Dysplasia of cervix uteriGCST904542181.52e-04
11293Crohn's disease of small intestineFING000003691.52e-04
11294CACYBP levelsGCST904685241.52e-04
11295CCL2/CCL7 ratioGCST903136961.52e-04
11296CD83 levelsGCST904686521.51e-04
11297Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST904760651.51e-04
11298HSPG2/VASN ratioGCST903150941.51e-04
11299DBNL/HSPA1A ratioGCST903144181.51e-04
11300METAP2/PLPBP ratioGCST903154321.50e-04
11301CTRB1/KIRREL2 ratioGCST903143061.50e-04
11302Dementia due to Parkinson's disease (more control exclusions)FING000003921.50e-04
11303Mean platelet volume during third trimester of pregnancyGCST903022311.49e-04
11304Right ventricular peak atrial filling rateGCST902681191.49e-04
11305CTSV levelsGCST904689171.49e-04
11306CD69/NFATC1 ratioGCST903138791.49e-04
11307IL22 levelsGCST904695821.49e-04
11308FCGR2A levelsGCST904692001.49e-04
11309BACH1/CNST ratioGCST903134361.48e-04
11310Docosahexaenoic acid levelsGCST905022591.48e-04
11311CDON/SCARA5 ratioGCST903139951.47e-04
11312BSG/CKAP4 ratioGCST903135311.47e-04
11313IPCEF1/SPARC ratioGCST903151861.47e-04
11314Other peripheral vertigoFING000010881.46e-04
11315Ceramide (d18:1/24:0) levelsGCST900240461.46e-04
11316Estimated glomerular filtration rate (creatinine)GCST901036341.46e-04
11317ATRN levelsGCST904684001.45e-04
11318Cholesterol to Total Lipids in Small HDL percentageGCST904993731.45e-04
11319KLK11 levelsGCST904696971.44e-04
11320PDGFB/ST6GAL1 ratioGCST903156301.44e-04
11321Bone marrow fat fraction of right proximal femurGCST906523931.44e-04
11322DKK1/IPCEF1 ratioGCST903144711.44e-04
11323rfMRI amplitudes (ICA100 node 30)GCST900046181.43e-04
11324aseg global volume CC-AnteriorGCST900026111.43e-04
11325PATE4 levelsGCST902424051.43e-04
11326DBI/MESD ratioGCST903144091.41e-04
11327DTI TBSS MO Medial lemniscus LGCST903846291.41e-04
11328DECR1/METAP1D ratioGCST903144481.40e-04
11329CLEC1B/SORT1 ratioGCST903141041.40e-04
11330Lymphocyte countGCST900023171.40e-04
11331Dermatomycosis (PheCode 110.2)GCST904755651.40e-04
11332ANGPT1/CCN2 ratioGCST903132611.39e-04
11333Average diameter for HDL particlesGCST904974461.38e-04
11334UGDH levelsGCST904710061.38e-04
11335EPHB6/LAYN ratioGCST903146811.38e-04
11336PTX3 levelsGCST904703921.38e-04
11337Varicose veinsGCST900861441.37e-04
11338F-carbohydrate liking (derived food-liking factor)GCST900947251.37e-04
11339Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING000002401.37e-04
11340PDGFB/SNAP29 ratioGCST903156271.36e-04
11341BCR/CLIP2 ratioGCST903134861.36e-04
11342Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024141.36e-04
11343KLK10 levelsGCST904696961.36e-04
11344ERBB2/FURIN ratioGCST903146861.35e-04
11345VWC2L levelsGCST904710631.35e-04
11346CLEC1B/LGALS8 ratioGCST903140961.35e-04
11347CAMKK1/FOXO1 ratioGCST903136131.35e-04
11348MMP12 levelsGCST900120701.35e-04
11349CLEC1B/HEXIM1 ratioGCST903140931.34e-04
11350ALB levelsGCST900928071.34e-04
11351TIMM8A levelsGCST904708681.33e-04
11352LGMN levelsGCST904697661.32e-04
11353Duodenal ulcerFING000004811.32e-04
11354CD226 levelsGCST904686091.31e-04
11355KYNU levelsGCST904697221.31e-04
11356Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)FING000000411.31e-04
11357Anterior thigh muscle fat infiltration percentageGCST902673511.30e-04
11358CKAP4/LAMP3 ratioGCST903140731.30e-04
11359Ectropion or entropion (PheCode 374.1)GCST904758911.30e-04
11360FUT8/PDGFA ratioGCST903148901.29e-04
11361ERBIN/TBC1D23 ratioGCST903146981.29e-04
11362FGF23 levelsGCST900120221.29e-04
11363CD244/CRTAM ratioGCST903137631.28e-04
11364LAT/SERPINE1 ratioGCST903152871.28e-04
11365Infective dermatitisFING000006731.27e-04
11366HDGF levelsGCST904694421.27e-04
11367Eosinophil countGCST900259871.26e-04
11368Thyroid peroxidase antibody positivity in pregnancyGCST904352021.25e-04
11369PALM3 levelsGCST904701531.25e-04
11370DKK1/VEGFC ratioGCST903144841.25e-04
11371ENTPD5 levelsGCST902410241.25e-04
11372SERPINA4 levelsGCST904705841.25e-04
11373ITGB2 levelsGCST904696441.24e-04
11374MMP9/OSM ratioGCST903154681.24e-04
11375Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB000001001.23e-04
11376CIAPIN1/SPARC ratioGCST903140691.22e-04
11377lymphocyte (absolute count, minimum, inv-norm transformed)GCST904754291.22e-04
11378SMPD3 levelsGCST904706851.22e-04
11379Lymphocyte countGCST0046271.22e-04
11380Concentration of small HDL particles (UKB data field 23572)GCST902696691.22e-04
11381IDP dMRI TBSS MD Cerebral peduncle LGCST900040421.21e-04
11382TIMM10 levelsGCST904708671.21e-04
11383Calculus of kidney (PheCode 594.1)GCST904761451.21e-04
11384GIMAP7 levelsGCST904693451.20e-04
11385Skin sebum (glabella)GCST905027971.20e-04
11386CELA3A/CPB1 ratioGCST903140101.20e-04
11387CD99 levelsGCST904686581.19e-04
11388LGALS3BP levelsGCST904697601.18e-04
11389CD84/SORT1 ratioGCST903139181.18e-04
11390SERPINB1/SERPINB9 ratioGCST903158271.18e-04
11391XCL1 levelsGCST904710811.17e-04
11392IL1R2/MEGF9 ratioGCST903151591.17e-04
11393MAPRE3 levelsGCST904698591.17e-04
11394FABP4/SNCG ratioGCST903147591.17e-04
11395Neonatal jaundice (paternal effect)GCST904351471.16e-04
11396EREG/F2R ratioGCST903147001.15e-04
11397TCN2 levelsGCST904708201.15e-04
11398CD74/JAM2 ratioGCST903138931.15e-04
11399Rheumatoid arthritis | musculoskeletalUKBB000007571.15e-04
11400PHOSPHO1 levelsGCST904702271.14e-04
11401CDHR5 levelsGCST904686801.14e-04
11402Mean spheric corpuscular volumeGCST900023971.14e-04
11403CC2D1A/TMSB10 ratioGCST903136671.14e-04
11404CLTA levelsGCST904687911.13e-04
11405SNX9/STIP1 ratioGCST903158641.12e-04
11406Cholesterol in small HDL (UKB data field 23575)GCST902696721.12e-04
11407DNMBP/PTPN1 ratioGCST903145171.12e-04
11408CD48 levelsGCST904686351.12e-04
11409HS1BP3 levelsGCST904694771.11e-04
11410FLI1 levelsGCST904692471.11e-04
11411EDAR/F11R ratioGCST903145761.11e-04
11412Treatment/medication code - levothyroxine sodium | MedicationsUKBB000008491.10e-04
11413Rheumatoid arthritisGCST901322231.10e-04
11414SERPINE1/SMAD1 ratioGCST903158331.08e-04
11415CTSL levelsGCST904689141.08e-04
11416GlaucomaGCST904681291.08e-04
11417STX4 levelsGCST904707721.07e-04
11418Allergic disease (asthma, hay fever or eczema)GCST0050381.07e-04
11419ADAMTS16 levelsGCST904682241.07e-04
11420VEGFB levelsGCST904710351.07e-04
11421Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levelsGCST902001451.07e-04
11422PTRHD1 levelsGCST904703891.07e-04
11423Cholesteryl Esters in HDLGCST904973681.07e-04
11424PECAM1 levelsGCST904702061.07e-04
11425CPVL levelsGCST904688481.06e-04
11426Glycine levelsGCST0076381.05e-04
11427NBL1/NECTIN4 ratioGCST903155141.05e-04
11428NMI levelsGCST904700561.05e-04
11429CRTAM/GZMA ratioGCST903142751.05e-04
11430CD46/THBD ratioGCST903138361.04e-04
11431LAIR2 levelsGCST904697291.03e-04
11432Cerebrospinal fluid S-1-pyrroline-5-carboxylate levelsGCST903182351.03e-04
11433Cholesterol to total lipids in very large HDL percentage (UKB data field 23630)GCST902697271.02e-04
11434Right ventricular stroke volumeGCST901345901.02e-04
11435PDGFB/PTPN6 ratioGCST903156251.02e-04
11436AsthmaGCST0100421.02e-04
11437PGD levelsGCST904702171.01e-04
11438HDL cholesterol levelsGCST904973521.01e-04
11439EDAR/SPARC ratioGCST903145881.01e-04
11440BAG6/USP8 ratioGCST903134511.01e-04
11441DiverticulitisGCST904681251.00e-04
11442HAVCR2 levelsGCST904215159.99e-05
11443neutrophil (fraction, mean, inv-norm transformed)GCST904755389.96e-05
11444PsoriasisFING000012229.93e-05
11445Gestational [pregnancy-induced] oedema and proteinuria without hypertensionFING000005729.92e-05
11446Seen a psychiatrist for nerves, anxiety, tension or depression | Mental healthUKBB000007649.89e-05
11447Cerotoylcarnitine (C26) levelsGCST902001369.85e-05
11448BCR/VASH1 ratioGCST903134999.83e-05
11449GLO1 levelsGCST904693589.82e-05
11450CLEC1B/SNAP29 ratioGCST903141039.81e-05
11451Mean sphered cell volume | Blood countUKBB000004529.79e-05
11452ACOX1/VSIR ratioGCST903131559.71e-05
11453ILKAP levelsGCST904696089.70e-05
11454INHBB levelsGCST904696149.70e-05
11455Rosacea (PheCode 695.3)GCST904761789.69e-05
11456TNFSF13B levelsGCST904709209.64e-05
11457ENO2/MANF ratioGCST903146629.59e-05
11458CLEC1B/TXNDC5 ratioGCST903141059.58e-05
11459PARP1 levelsGCST904701609.54e-05
11460SIGLEC10 levelsGCST904706309.44e-05
11461Free cholesterol in HDL (UKB data field 23422)GCST902695199.42e-05
11462CD55/CHI3L1 ratioGCST903138459.41e-05
11463Other systemic involvement of connective tissue (FG)FING000011169.40e-05
11464SIGLEC8 levelsGCST904706369.37e-05
11465UrticariaGCST900187169.35e-05
11466Acute upper respiratory infections of multiple and unspecified sitesFING000000359.28e-05
11467ARHGEF12/IRAK4 ratioGCST903133509.27e-05
11468Myocardial fractal dimension (slice 3)GCST900002899.23e-05
11469HBEGF/PDGFB ratioGCST903150349.21e-05
11470Usual side of head for mobile phone use - Equally left and right | Electronic device useUKBB000008889.16e-05
11471CST6/NECTIN4 ratioGCST903143039.15e-05
11472VSIR levelsGCST904710539.15e-05
11473IGFBP3 levelsGCST904695299.15e-05
11474DAB2/ERBIN ratioGCST903143619.07e-05
11475PHACTR2 levelsGCST904702249.04e-05
11476CTRC/PLA2G1B ratioGCST903143109.01e-05
11477IMPACT levelsGCST904696119.00e-05
11478KIT levelsGCST904696928.98e-05
11479IL5RA levelsGCST904696008.97e-05
11480Triacylglycerol_50:2_[M+NH4]1+ levelsGCST900604738.95e-05
11481Free cholesterol in large VLDLGCST904981858.86e-05
11482Stable angina pectorisGCST900186958.86e-05
11483ThyrotoxicosisFING000013608.80e-05
114843,5-dichloro-2,6-dihydroxybenzoic acid levelsGCST902002528.80e-05
11485LAG3 levelsGCST904697278.80e-05
11486CA9/CBLIF ratioGCST903135958.77e-05
11487ATP5IF1 levelsGCST904683928.75e-05
11488Volume of right cortico-amygdaloid transition areaGCST904750188.67e-05
11489FCRL6/GZMA ratioGCST903148068.65e-05
11490HypothyroidismGCST902041678.64e-05
11491Citrate levelsGCST902434428.60e-05
11492DDAH1 levelsGCST904689668.56e-05
11493DKK1/MGLL ratioGCST903144738.55e-05
11494SLAMF7/TXNDC15 ratioGCST903158508.54e-05
11495PTPRM levelsGCST904703848.53e-05
11496Phosphatidylcholine diacyl C38:4 levelsGCST902400468.53e-05
11497PDIA4 levelsGCST904701958.51e-05
11498Savoury biscuit likingGCST900948348.50e-05
11499COLEC12/TGFBR2 ratioGCST903141868.42e-05
11500COL6A3/TAFA5 ratioGCST903141808.40e-05
11501MILR1 levelsGCST904699078.28e-05
11502TWF2 levelsGCST904709878.26e-05
11503Free Cholesterol to Total Lipids in Medium HDL percentageGCST904985808.25e-05
11504HGF/MMP9 ratioGCST903150568.18e-05
11505Hypothyroidism | endocrine/metabolicUKBB000003358.12e-05
11506CBLIF levelsGCST904685528.09e-05
11507GRAP2/PPP1R2 ratioGCST903149858.08e-05
11508FCRL6 levelsGCST904692098.08e-05
11509T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66)GCST903206298.03e-05
11510ERP44/SUMF2 ratioGCST903147108.02e-05
11511GNLY levelsGCST904693727.99e-05
11512F2R/PDGFB ratioGCST903147337.92e-05
11513Body fat percentageGCST901037527.87e-05
11514FGD3 levelsGCST904692177.82e-05
11515Spleen volumeGCST900166677.78e-05
11516RSPO1/RSPO3 ratioGCST903157907.77e-05
11517DDHD2 levelsGCST904689687.77e-05
11518SNAP23/TXLNA ratioGCST903158577.70e-05
11519SCAMP3/STX4 ratioGCST903158057.66e-05
11520NUMB levelsGCST904701087.64e-05
11521ThalamNuclei lh volume Whole-thalamusGCST900027627.61e-05
11522GATD3 levelsGCST904693097.59e-05
11523WFDC1 levelsGCST904710747.55e-05
11524REG1B/REG3A ratioGCST903157657.54e-05
11525Concentration of large HDL particles (UKB data field 23558)GCST902696557.54e-05
11526NPTX1 levelsGCST904700787.53e-05
11527GlaucomaGCST900186327.48e-05
11528DAB2/VASH1 ratioGCST903143697.43e-05
11529Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB000005187.42e-05
11530GPC1/ITGB6 ratioGCST903149777.40e-05
11531AKT1S1/MAX ratioGCST903132307.35e-05
11532Thyroid peroxidase antibody levels in pregnancyGCST904352017.33e-05
11533CCL2 levelsGCST904685817.31e-05
11534Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levelsGCST900602707.25e-05
11535Plasma pregnenetriol sulfate* levels in chronic kidney diseaseGCST902658667.24e-05
11536PDGFB/PPP1R12A ratioGCST903156237.21e-05
11537Lichen simplex chronicus and prurigoFING000007257.19e-05
11538CNST/DOK2 ratioGCST903141577.18e-05
11539PLXNB2/SEMA7A ratioGCST903156927.15e-05
11540mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST904754427.15e-05
11541ATP5IF1/HSPA1A ratioGCST903133887.15e-05
11542Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB000005097.15e-05
11543Free cholesterol levels in small HDLGCST900929487.13e-05
11544ENG/TNFSF10 ratioGCST903146517.13e-05
11545MS-disease / Multiple SclerosisFING000008397.08e-05
11546DTI TBSS L2 Genu of corpus callosumGCST903844787.07e-05
11547Lymphocyte countGCST900259847.06e-05
11548Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levelsGCST900604236.95e-05
11549TNFRSF17 levelsGCST904709086.92e-05
11550CRKL/MANF ratioGCST903142696.89e-05
11551Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST901322276.84e-05
11552Triglycerides to Total Lipids in Very Large HDL percentageGCST905005066.79e-05
11553DTI autoptx FA unc r tractGCST903851386.79e-05
11554Phosphatidylcholine-2O_32:0_[M+H]1+ levelsGCST900602446.78e-05
11555Adhesive capsulitis of shoulderFING000000436.78e-05
11556Pilonidal cystFING000011676.72e-05
11557CLEC1B/PPP1R2 ratioGCST903141016.66e-05
11558FCAR levelsGCST904691976.65e-05
11559Disorders of iron metabolism (PheCode 275.1)GCST904757436.57e-05
11560HGF levelsGCST904694496.55e-05
11561ALB levelsGCST904751066.50e-05
11562ADAM22 levelsGCST904682186.49e-05
11563CA6 levelsGCST904685156.49e-05
11564FOLH1 levelsGCST902412726.48e-05
11565OGN levelsGCST904701196.45e-05
11566CSF3R levelsGCST904688856.42e-05
11567TBCA levelsGCST904708126.40e-05
11568Allergic asthma (mode)FING000000666.38e-05
11569Plasma 1-methylurate levels in chronic kidney diseaseGCST902642406.36e-05
11570ATG4A levelsGCST904683846.34e-05
11571RSPO3 levelsGCST904705046.32e-05
11572ESAM/JAM2 ratioGCST903147126.29e-05
11573Principal component-derived dietary pattern 44GCST901330496.28e-05
11574Calcium | Blood biochemistryUKBB000001146.26e-05
11575AsthmaGCST900143256.24e-05
11576FKBP5/MAP4K5 ratioGCST903148436.18e-05
11577UROD levelsGCST904710166.08e-05
11578CSTB levelsGCST904688986.05e-05
11579Cholesteryl ester levels in small HDLGCST900929466.03e-05
11580SNAP29/VEGFC ratioGCST903158626.02e-05
11581CLEC1B/MGLL ratioGCST903140976.01e-05
11582Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB000005066.01e-05
11583PDGFA/VEGFC ratioGCST903156226.00e-05
11584Free Cholesterol in HDLGCST904973815.97e-05
11585Operation code - wisdom teeth surgery | OperationsUKBB000005695.95e-05
11586REG1A levelsGCST904704475.93e-05
11587CRELD2/F2R ratioGCST903142545.90e-05
11588BSG/LAMP3 ratioGCST903135335.88e-05
11589Methionine sulfone levelsGCST901999615.86e-05
11590DKK1/PPCDC ratioGCST903144775.81e-05
11591CRADD/DARS1 ratioGCST903142345.80e-05
11592PLA2G15/PRCP ratioGCST903156615.80e-05
11593N6-acetyllysine levels in chronic kidney diseaseGCST902575315.79e-05
11594DAG1/SCARF1 ratioGCST903143815.75e-05
11595Non-albumin protein levelsUKBB000005035.74e-05
11596SOD2 levelsGCST904707055.72e-05
11597COL6A3 levelsGCST904688215.72e-05
11598Clonal hematopoiesis (overall)GCST904353535.70e-05
11599ANGPT1/PDGFA ratioGCST903132665.70e-05
11600ICOSLG levelsGCST904695035.69e-05
11601Asthma (adult onset)GCST0077995.67e-05
11602Noninfective enteritis and colitisFING000008815.61e-05
11603CPB1/REG1A ratioGCST903142125.60e-05
11604DCTN1/SCAMP3 ratioGCST903144335.58e-05
11605Calculus of lower urinary tract (PheCode 594.2)GCST904761465.55e-05
11606Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB000000595.55e-05
11607IL1RL2 levelsGCST904695755.54e-05
11608Concentration of large HDL particlesGCST900928515.54e-05
11609LAT2/SDC4 ratioGCST903152785.50e-05
11610MAMDC4 levelsGCST904698425.50e-05
11611VAV3 levelsGCST904710305.49e-05
11612DKK1/VASH1 ratioGCST903144825.48e-05
11613CALCOCO1/CASP8 ratioGCST903135975.45e-05
11614Hair colour (natural, before greying) - Black | Sun exposureUKBB000002955.45e-05
11615CLEC1B/RWDD1 ratioGCST903141025.42e-05
11616Lymphocyte count (UKB data field 30120)GCST904680825.40e-05
11617Ulcerative colitisGCST904760675.39e-05
11618AsthmaGCST904681125.38e-05
11619Mouth/teeth dental problems - Mouth ulcers | MouthUKBB000004885.35e-05
11620CLEC1B/NSFL1C ratioGCST903140995.33e-05
11621SERPINB1 levelsGCST904705895.26e-05
11622Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000155.26e-05
11623CD48/FCRL6 ratioGCST903138405.26e-05
11624CD164/CD99 ratioGCST903137405.24e-05
11625ADGRE5/SEMA7A ratioGCST903131835.20e-05
11626Arthropathies in other diseases classified elsewhereFING000001085.18e-05
11627ARHGAP25/RNF41 ratioGCST903133455.18e-05
11628PLEKHO1 levelsGCST904702565.17e-05
11629PAPPA levelsGCST900120365.16e-05
11630COLEC12 levelsGCST904688245.16e-05
11631CCS levelsGCST904685945.11e-05
11632CRACR2A/LBR ratioGCST903142285.08e-05
11633MEGF9 levelsGCST904698845.08e-05
11634LSP1 levelsGCST904698115.04e-05
11635MARCO/SIGLEC1 ratioGCST903153875.03e-05
11636KLRF1 levelsGCST904697124.96e-05
11637MDGA1 levelsGCST904698754.95e-05
11638PRSS2 levelsGCST902431264.89e-05
11639DPP6/SEZ6L2 ratioGCST903145434.85e-05
11640Lymphocyte countGCST900023884.85e-05
11641CD300A levelsGCST904686194.82e-05
11642Seronegative rheumatoid arthritisFING000012964.82e-05
11643high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753564.80e-05
11644Cucumber likingGCST900947494.80e-05
11645EDN1 levelsGCST904690734.80e-05
11646NCS1 levelsGCST904700114.78e-05
11647FCRL2/LY9 ratioGCST903147994.76e-05
11648CCL13/CCL2 ratioGCST903136754.76e-05
11649FCGR2B levelsGCST904692014.73e-05
11650APP/DAG1 ratioGCST903133204.70e-05
11651Diseases of external earFING000004244.69e-05
11652Charcot footFING000002684.68e-05
11653RPN1 levelsGCST902409644.68e-05
11654MPO levelsGCST904699374.67e-05
11655CD300E levelsGCST904686214.66e-05
11656RRAS levelsGCST904704994.63e-05
11657PDCD1LG2 levelsGCST904701804.63e-05
11658VAT1 levelsGCST904710294.61e-05
11659FLRT2 levelsGCST904692484.61e-05
11660ITGA5/SELE ratioGCST903152054.59e-05
11661CCN2/SERPINB1 ratioGCST903137154.58e-05
11662PDGFA/SCARF1 ratioGCST903156174.57e-05
11663FHIT levelsGCST904692384.55e-05
11664PDGFB/USP8 ratioGCST903156334.55e-05
11665KITLG levelsGCST904696914.50e-05
11666SORT1 levelsGCST904707104.44e-05
11667Recent feelings of inadequacy | DepressionUKBB000007394.41e-05
11668PSIP1 levelsGCST904703544.41e-05
11669MMP9 levelsGCST904699234.38e-05
11670CDKN2D levelsGCST904686854.37e-05
11671GM3 ganglioside (d18:1/24:0) levelsGCST900247294.37e-05
11672Pain type(s) experienced in last month - Pain all over the body | PainUKBB000006324.37e-05
11673DIABLO/MITD1 ratioGCST903144674.35e-05
11674BSG/PCDH1 ratioGCST903135354.34e-05
11675HippSubfield rh volume Hippocampal-tailGCST900026904.33e-05
11676NFATC1/TJAP1 ratioGCST903155404.32e-05
11677CRTAM/FCRL6 ratioGCST903142744.32e-05
11678Free cholesterol in large HDL (UKB data field 23563)GCST902696604.25e-05
11679Skin cancer | neoplasmsUKBB000007724.25e-05
11680Fasting glucoseGCST900022314.23e-05
11681CDH3/NECTIN4 ratioGCST903139524.22e-05
11682Valine levelsGCST902434534.22e-05
11683DAB2/NCK2 ratioGCST903143674.22e-05
11684NOTCH3 levelsGCST904700674.21e-05
11685TNFRSF13C/TNFSF13B ratioGCST903159344.16e-05
11686CASP3/PDGFA ratioGCST903136374.11e-05
11687RNF41 levelsGCST904704854.09e-05
11688DLL1/NBL1 ratioGCST903144964.09e-05
11689Primary sclerosing cholangitisGCST0040304.08e-05
11690Cholesteryl esters in large HDL (UKB data field 23562)GCST902696594.05e-05
11691Depressive episode | Mood [affective] disordersUKBB000001664.05e-05
11692Cholesterol in large HDL (UKB data field 23561)GCST902696584.04e-05
11693ANXA3/ANXA4 ratioGCST903132784.04e-05
11694MUC2 levelsGCST904699654.04e-05
11695DIABLO/GRAP2 ratioGCST903144663.98e-05
11696EPHB6 levelsGCST904691333.96e-05
11697Diseases of middle ear and mastoidFING000004273.96e-05
11698CXCL10 levelsGCST902747803.93e-05
11699ERMAP levelsGCST904691473.91e-05
11700DAB2/GRAP2 ratioGCST903143643.90e-05
11701CCL18/RARRES2 ratioGCST903136903.88e-05
11702APRT/CD63 ratioGCST903133343.87e-05
11703S100A12 levelsGCST904705133.87e-05
11704GFER/VASH1 ratioGCST903149223.86e-05
11705rfMRI amplitudes (ICA25 node 12)GCST900045793.85e-05
11706ITGB1BP2/LAT2 ratioGCST903152123.82e-05
11707Free cholesterol levels in large HDLGCST900928483.72e-05
11708PSRC1/SORT1 ratioGCST903157423.70e-05
11709Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB000000983.68e-05
11710Disorders of ocular muscles, binocular movement, accommodation and refractionFING000004463.66e-05
11711RETN levelsGCST900120343.66e-05
11712CEP20 levelsGCST904687123.63e-05
11713Gastroduodenal ulcerFING000005653.61e-05
11714CTSL levelsGCST900120733.59e-05
11715DLL1 levelsGCST904690043.58e-05
11716DTI TBSS MD Superior fronto-occipital fasciculus RGCST903846143.55e-05
11717OGA levelsGCST904701173.54e-05
11718Free cholesterol in small HDLGCST904994253.51e-05
11719GPI levelsGCST904693913.49e-05
11720ATP5IF1/METAP1D ratioGCST903133913.48e-05
11721PLB1 levelsGCST904702533.45e-05
11722IDP T1 FAST ROIs L temporal poleGCST900024653.45e-05
11723Phospholipids to total lipids ratio in large LDLGCST900928653.44e-05
11724LCN2/S100A12 ratioGCST903153093.42e-05
11725QDPR levelsGCST904704003.41e-05
11726IL6 levelsGCST904696043.38e-05
11727PCDH1/TNFRSF11A ratioGCST903156083.35e-05
11728Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024103.35e-05
11729TXNRD1 levelsGCST904709943.34e-05
11730DIABLO levelsGCST904689943.32e-05
11731FGFR2 levelsGCST904692333.31e-05
11732SERPINC1 levelsGCST904705943.29e-05
11733PLA2G15/SMPDL3A ratioGCST903156633.28e-05
11734Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levelsGCST900602843.27e-05
11735PDGFB/PRKAR1A ratioGCST903156243.26e-05
11736KLRD1 levelsGCST904697113.26e-05
11737Allergic conjunctivitisFING000000673.23e-05
11738HGFAC levelsGCST904694483.23e-05
11739CD22/TCL1A ratioGCST903137603.22e-05
11740TMSB10/TXNRD1 ratioGCST903159253.20e-05
11741CCL17/CCL22 ratioGCST903136823.18e-05
11742DNAJB1/PPME1 ratioGCST903145103.17e-05
11743Total lipid levels in large HDLGCST900928503.16e-05
11744DDX58 levelsGCST904689773.15e-05
11745Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivityGCST903026483.14e-05
11746TIMD4 levelsGCST904708663.14e-05
11747DTI TBSS MD Genu of corpus callosumGCST903845743.14e-05
11748CXCL11/SDC4 ratioGCST903143363.13e-05
11749TNFRSF8/TNFRSF9 ratioGCST903159403.13e-05
11750Bursitis (PheCode 726.3)GCST904762403.10e-05
11751CIAPIN1/SNAP29 ratioGCST903140673.10e-05
11752COPD/asthma/ILD related infectionsFING000003533.09e-05
11753Phospholipids to total lipids ratio in very large HDLGCST900930133.06e-05
11754LAT2/SERPINB1 ratioGCST903152793.06e-05
11755EFCAB14 levelsGCST904690763.00e-05
11756APRT/NSFL1C ratioGCST903133373.00e-05
11757LRIG1 levelsGCST904697942.93e-05
11758GPHA2 levelsGCST904693892.92e-05
11759SEC31A levelsGCST904705632.89e-05
11760LAMP3 levelsGCST904697352.88e-05
11761RNASET2 levelsGCST904704812.81e-05
11762Vitamin D levelsGCST0053672.81e-05
11763ALB levelsGCST902695762.80e-05
11764IL15/KLRD1 ratioGCST903151492.78e-05
11765CLEC1B/DIABLO ratioGCST903140872.76e-05
11766Fasting plasma glucoseGCST905664202.74e-05
11767AK1 levelsGCST904682692.74e-05
11768Alkaline phosphatase | Blood biochemistryUKBB000000272.73e-05
11769F11R/SORT1 ratioGCST903147262.73e-05
11770GOLM2/STC1 ratioGCST903149522.69e-05
11771Inflammatory bowel diseaseGCST904321822.67e-05
11772SCARB2 levelsGCST904705352.67e-05
11773DKK1/PTPN6 ratioGCST903144782.66e-05
11774Acetone levels (UKB data field 23477)GCST902695742.64e-05
11775Mean corpuscular volumeGCST900023352.64e-05
11776IGF2R levelsGCST904695262.63e-05
11777ABHD14B/SPARC ratioGCST903131462.61e-05
11778OGFR levelsGCST904701182.57e-05
11779Lymphocyte count | Blood countUKBB000004112.55e-05
11780IFNG levelsGCST904695152.55e-05
11781IPCEF1/SERPINE1 ratioGCST903151842.54e-05
11782STC1 levelsGCST904707612.54e-05
11783Gestational diabetes mellitusGCST905664192.54e-05
11784Lymphocyte percentage of white cellsGCST0046322.52e-05
11785Clonal haematopoiesis of indeterminate potential (with or without mosaic chromosomal alteration)GCST901652672.50e-05
11786ADA2/VCAM1 ratioGCST903131672.49e-05
11787NID1/NID2 ratioGCST903155412.48e-05
11788MYH9 levelsGCST904699752.46e-05
11789Acquired hypothyroidism (PheCode 244.2)GCST904756502.46e-05
11790IGF2R/RNASET2 ratioGCST903151322.44e-05
11791IDP dMRI TBSS L1 Retrolenticular part of internal capsule LGCST900040962.44e-05
11792JAM2/TNFRSF14 ratioGCST903152402.41e-05
11793CXCL3/CXCL5 ratioGCST903143442.41e-05
11794Volume of left accessory basal nucleusGCST904748742.41e-05
11795TXNDC15 levelsGCST904709902.41e-05
11796CSF1R levelsGCST904688802.40e-05
11797F2R/MPIG6B ratioGCST903147322.38e-05
11798BSG/LY9 ratioGCST903135342.37e-05
11799Lymphocyte countGCST900023162.37e-05
11800SCRN1 levelsGCST904705562.37e-05
11801CNTNAP2 levelsGCST904688082.35e-05
11802Acute renal failureFING000000302.34e-05
11803WASHC3 levelsGCST904710692.33e-05
11804CLEC4D/TGFA ratioGCST903141172.31e-05
11805N-acetyl-1-methylhistidine levelsGCST902006902.31e-05
11806HPCAL1/SERPINB9 ratioGCST903150792.30e-05
11807Other noninfective gastroenteritis and colitisFING000010772.30e-05
11808CD207 levelsGCST904686072.29e-05
11809Oral glucose tolerance test-1hGCST905664222.28e-05
11810Sexual abuseGCST905518372.28e-05
11811Omega-3 fatty acid levelsGCST905024412.27e-05
11812CDHR1 levelsGCST904686782.27e-05
11813Type 1 diabetesGCST900005292.27e-05
11814Free cholesterol in very large HDLGCST905003832.27e-05
11815NSFL1C/UBAC1 ratioGCST903155652.26e-05
11816Ulcerative colitisGCST904753222.26e-05
11817Crohn's diseaseGCST0041322.26e-05
11818EGF/MGLL ratioGCST903146102.25e-05
11819S100G levelsGCST904705192.25e-05
11820Mean reticulocyte volumeGCST900259752.24e-05
11821ITGB7 levelsGCST904696472.23e-05
11822SFTPA2 levelsGCST904706132.22e-05
11823PDGFB/SDC4 ratioGCST903156262.22e-05
11824DRG2 levelsGCST904690392.20e-05
11825TFPI2 levelsGCST904708382.19e-05
11826Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST900425352.19e-05
11827Alanine aminotransferase levelsGCST900187232.17e-05
11828Histidine levelsGCST902434042.17e-05
11829PDGFB/TNFSF13 ratioGCST903156322.16e-05
11830Phospholipid levels in large HDLGCST900928522.15e-05
11831high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753522.14e-05
11832PPIF levelsGCST904702932.13e-05
11833CEP43/MPHOSPH8 ratioGCST903140192.13e-05
11834CD84/GP6 ratioGCST903139142.13e-05
11835Cervical cancerGCST900185972.13e-05
11836APBB1IP levelsGCST904683272.12e-05
11837APRT/PSME1 ratioGCST903133382.11e-05
11838SDC4/SMAD1 ratioGCST903158202.11e-05
11839L1CAM/SEZ6L ratioGCST903152662.10e-05
11840EDAR/F2R ratioGCST903145772.09e-05
11841GRAP2/PLPBP ratioGCST903149842.06e-05
11842ABHD14B levelsGCST904681892.06e-05
11843ABHD14B/CCS ratioGCST903131392.05e-05
11844GMFG levelsGCST904693662.04e-05
11845Urinary tryptophan to urinary creatinine ratioGCST904517482.04e-05
11846Lysophosphatidylethanolamine-P_20:0_[M-H]1- levelsGCST900601472.03e-05
11847FABP4/FGF21 ratioGCST903147582.03e-05
11848EGF/GP6 ratioGCST903146082.02e-05
11849Chronic iridocyclitisFING000002872.01e-05
11850DNMBP/WWP2 ratioGCST903145221.99e-05
11851AGRN/HSPG2 ratioGCST903132011.98e-05
11852ARSB levelsGCST904683691.95e-05
11853CCL11/CCL7 ratioGCST903136731.95e-05
11854Acute myocardial infarction | Ischaemic heart diseasesUKBB000000111.94e-05
11855Cholesteryl ester (16:2) levelsGCST900252381.91e-05
11856EGF/MPIG6B ratioGCST903146111.89e-05
11857Omega-3 fatty acids to total fatty acids percentageGCST905024671.88e-05
11858Phospholipids in large LDLGCST904980491.87e-05
11859CRTAM/LY9 ratioGCST903142781.86e-05
11860Vitamin B12 deficiency anaemiaFING000014411.85e-05
11861CD69/CLEC1B ratioGCST903138691.85e-05
11862Pyruvate levels (UKB data field 23472)GCST902695691.83e-05
11863DBNL levelsGCST904689511.82e-05
11864CD22/SEMA7A ratioGCST903137591.82e-05
11865REG1B levelsGCST904704481.81e-05
11866AXIN1/NFATC1 ratioGCST903134151.79e-05
11867ABL1/DNMBP ratioGCST903131491.79e-05
11868DAG1/DKK1 ratioGCST903143731.79e-05
11869YWHAQ levelsGCST904710921.77e-05
11870MMP8 levelsGCST904699221.76e-05
11871SRSF7 levelsGCST902427711.74e-05
11872Crohn's disease NASFING000003671.74e-05
11873CNTN3/FETUB ratioGCST903141641.71e-05
11874AK1/PEBP1 ratioGCST903132251.71e-05
11875FGA levelsGCST904692161.71e-05
11876PRKAB1 levelsGCST904703241.70e-05
11877ALB levelsGCST904971011.69e-05
11878Coriander likingGCST900947441.69e-05
11879DPEP1 levelsGCST904690301.69e-05
11880CCL17/F2R ratioGCST903136861.69e-05
11881F2R/SERPINE1 ratioGCST903147351.69e-05
11882APOD levelsGCST904683371.67e-05
11883Thyroiditis, unspecifiedFING000013591.67e-05
11884CCL14 levelsGCST904685661.66e-05
11885DAG1/PDGFA ratioGCST903143781.65e-05
11886CD209 levelsGCST904686081.61e-05
11887TXNL1 levelsGCST904709931.60e-05
11888Medication use (immunosuppressants)GCST900187711.60e-05
11889ALB/Globulin ratioUKBB000000201.59e-05
11890Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING000007641.58e-05
11891IGF1 levelsGCST900259891.57e-05
11892DLK1/RGMB ratioGCST903144931.56e-05
11893Free cholesterol in very large HDL (UKB data field 23556)GCST902696531.56e-05
11894DNAJA2/PLXNA4 ratioGCST903145041.56e-05
11895HypothyroidismGCST903193201.53e-05
11896DPP7 levelsGCST904690351.52e-05
11897SNX9/VASH1 ratioGCST903158661.51e-05
11898CFC1 levelsGCST904687241.51e-05
11899X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levelsGCST902436191.49e-05
11900NCR1 levelsGCST904700091.48e-05
11901ENG/PEAR1 ratioGCST903146491.46e-05
11902KITLG levelsGCST900120231.45e-05
11903Thyroid stimulating hormone levels within normal range in pregnancyGCST904351951.45e-05
11904GIPC2 levelsGCST904693471.45e-05
11905MPIG6B/PLXNA4 ratioGCST903154831.44e-05
11906Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023981.43e-05
11907CA5A/GRPEL1 ratioGCST903135901.43e-05
11908ANPEP/NT5E ratioGCST903132741.43e-05
11909CCL19 levelsGCST904685711.42e-05
11910GORASP2 levelsGCST904693781.41e-05
11911ITIH3 levelsGCST904696501.40e-05
11912TNFSF14 levelsGCST904709221.39e-05
11913Ulcerative colitisGCST904467951.38e-05
11914LY6D/WFDC12 ratioGCST903153461.37e-05
11915DTI autoptx L2 fmi tractGCST903851771.35e-05
11916TGOLN2 levelsGCST904708501.33e-05
11917CAPS levelsGCST904685391.33e-05
11918GZMA/LTA ratioGCST903150121.33e-05
11919PZP levelsGCST904703991.31e-05
11920Volume of left anterior amygdaloid areaGCST904749371.30e-05
11921Ulcerative colitisGCST0041331.29e-05
11922Mean corpuscular volumeGCST900187461.29e-05
11923Regional enteritis (PheCode 555.1)GCST904760661.28e-05
11924RNF149 levelsGCST904704821.26e-05
11925CD84/DKK1 ratioGCST903139111.25e-05
11926SLAMF7 levelsGCST904706511.25e-05
11927Average diameter for HDL particles (UKB data field 23433)GCST902695301.24e-05
11928CRTAM levelsGCST904688711.23e-05
11929EIF4E levelsGCST904690961.23e-05
11930IL1RN levelsGCST900120041.23e-05
11931DBNL/PDGFB ratioGCST903144221.23e-05
11932Urine betaine levels in chronic kidney diseaseGCST902648591.21e-05
11933IDP dMRI TBSS ISOVF Sagittal stratum RGCST900045071.20e-05
11934SKAP2 levelsGCST904706461.19e-05
11935PLAU/PLAUR ratioGCST903156741.19e-05
11936TPP1 levelsGCST904709461.16e-05
11937TBC1D23 levelsGCST904708101.16e-05
11938CD27/NECTIN4 ratioGCST903137751.16e-05
11939BLOC1S3 levelsGCST904684501.16e-05
11940F9/FURIN ratioGCST903147471.16e-05
11941GALNT10/TNFSF12 ratioGCST903149161.15e-05
11942EBAG9/TGFB1 ratioGCST903145701.15e-05
11943BGN levelsGCST904684411.15e-05
11944GoutGCST903997001.15e-05
11945ADGRE5/ITGB2 ratioGCST903131801.13e-05
11946IL5RA/TNFRSF13B ratioGCST903151641.13e-05
11947CA6/DNER ratioGCST903135941.12e-05
11948KLB levelsGCST904696931.12e-05
11949Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivityGCST903026931.11e-05
11950TALDO1 levelsGCST904708021.11e-05
11951Free Cholesterol to Total Lipids in Small HDL percentageGCST904994361.10e-05
11952Fracture of radius and ulna (PheCode 803.2)GCST904762801.09e-05
11953ABHD14B/APRT ratioGCST903131371.09e-05
11954RNF41/WWP2 ratioGCST903157821.09e-05
11955CD63 levelsGCST904686421.08e-05
11956Cholesteryl esters in very large HDL (UKB data field 23555)GCST902696521.06e-05
11957Crohn's disease of large intestineFING000003681.06e-05
11958CCL3 levelsGCST904685821.06e-05
11959TNFRSF13C levelsGCST904709061.05e-05
11960Blood cell traits latent factor 8 (white cell)GCST905592501.05e-05
11961CCL26 levelsGCST904685781.04e-05
11962PLIN3/TYMP ratioGCST903156781.04e-05
11963HAVCR2/TNFRSF1B ratioGCST903150301.03e-05
11964OMD/SPP1 ratioGCST903155861.03e-05
11965HypothyroidismGCST904681381.03e-05
11966T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77)GCST903208961.02e-05
11967GZMH/KLRD1 ratioGCST903150161.02e-05
11968IridocyclitisFING000006961.01e-05
11969Phenylalanine levelsGCST904992281.00e-05
11970BACH1/DIABLO ratioGCST903134371.00e-05
11971TNFSF12 levelsGCST902748469.95e-06
11972CRKL/SERPINB1 ratioGCST903142729.91e-06
11973BCL2 levelsGCST904684339.81e-06
11974DBNL/VASH1 ratioGCST903144279.73e-06
11975Inflammatory bowel disease, strict (require KELA)FING000006759.71e-06
11976IPCEF1 levelsGCST904696249.71e-06
11977EczemaGCST904681269.61e-06
11978CCL18 levelsGCST904685709.53e-06
11979Primary biliary cholangitisGCST0031299.43e-06
11980CHI3L1 levelsGCST904687439.41e-06
11981Phospholipid levels in very large HDLGCST900930129.38e-06
11982CD244 levelsGCST902747719.18e-06
11983Acetone levelsGCST900928059.17e-06
11984CRELD2/TXNDC5 ratioGCST903142599.16e-06
11985PLCB2 levelsGCST904702559.13e-06
11986FOLH1 levelsGCST904271929.08e-06
11987DARS1/EIF4B ratioGCST903144039.01e-06
11988ADGRB3 levelsGCST904682348.98e-06
11989Skin luminanceGCST903202578.90e-06
11990MPIG6B/PDGFB ratioGCST903154828.81e-06
11991CD302/CD99 ratioGCST903138058.77e-06
11992Hypothyroidism, strict autoimmuneFING000006568.74e-06
11993NRGN levelsGCST904700838.72e-06
11994CST7 levelsGCST904688978.69e-06
11995Human herpes virus 7 U14 antibody levelsGCST900069098.66e-06
11996MECR levelsGCST904698798.65e-06
11997HBEGF levelsGCST900120678.61e-06
11998ERP44 levelsGCST904691508.52e-06
11999BIN2 levelsGCST904684458.48e-06
12000Mean platelet volumeGCST900023958.47e-06